Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 23423490)

1.

Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis.

Fushida S, Kinoshita J, Kaji M, Hirono Y, Goda F, Yagi Y, Oyama K, Sudo Y, Watanabe Y, Fujimura T; Society for Study of Peritoneal Carcinomatosis in Gastric Cancer.

Cancer Chemother Pharmacol. 2013 May;71(5):1265-72. doi: 10.1007/s00280-013-2122-0. Epub 2013 Feb 20.

2.

Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma.

Park SR, Kim HK, Kim CG, Choi IJ, Lee JS, Lee JH, Ryu KW, Kim YW, Bae JM, Kim NK.

Br J Cancer. 2008 Apr 22;98(8):1305-11. doi: 10.1038/sj.bjc.6604312. Epub 2008 Mar 25.

3.

Feasibility study of S-1 and intraperitoneal docetaxel combination chemotherapy for gastric cancer with peritoneal dissemination.

Fujiwara Y, Nishida T, Takiguchi S, Nakajima K, Miyata H, Yamasaki M, Yamamoto K, Moon JH, Mori M, Doki Y.

Anticancer Res. 2010 Apr;30(4):1335-9.

PMID:
20530449
4.

Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer.

Hironaka S, Yamazaki K, Taku K, Yokota T, Shitara K, Kojima T, Ueda S, Machida N, Muro K, Boku N.

Jpn J Clin Oncol. 2010 Nov;40(11):1014-20. doi: 10.1093/jjco/hyq104. Epub 2010 Jul 5.

5.

Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor.

Cui Y, Li Q, Yu Y, Chen Y, Feng Y, Wang Y, Liu T.

Cancer Chemother Pharmacol. 2013 Jan;71(1):145-52. doi: 10.1007/s00280-012-1991-y. Epub 2012 Oct 12.

PMID:
23064955
6.

Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age.

Zang DY, Yang DH, Lee HW, Hwang SW, Song HH, Jung JY, Kwon JH, Kim HJ, Kim JH, Park SR, Kim MJ, Jang KM, Park CK, Kim JH, Lee BH.

Cancer Chemother Pharmacol. 2009 Feb;63(3):509-16. doi: 10.1007/s00280-008-0768-9. Epub 2008 May 15.

PMID:
18481067
7.

Phase I dose escalation study of docetaxel with a fixed dose of S-1 in combination chemotherapy for advanced gastric cancer.

Kim YH, Seo HY, Jeen YT, Kim HK, Shim BY, Yang J.

Cancer Chemother Pharmacol. 2009 Jan;63(2):253-60. doi: 10.1007/s00280-008-0734-6. Epub 2008 May 21.

PMID:
18493761
8.

Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination.

Fujiwara Y, Takiguchi S, Nakajima K, Miyata H, Yamasaki M, Kurokawa Y, Mori M, Doki Y.

J Surg Oncol. 2012 Jan;105(1):38-42. doi: 10.1002/jso.22057. Epub 2011 Aug 31.

PMID:
21882194
9.

Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer.

Zang DY, Yang DH, Kim MJ, Jang KM, Hwang SW, Yoo KS, Han T, Kim HY, Kim HJ, Kwon JH, Song HH, Park S, Jung JY, Kim HS, Kim JH.

Cancer Chemother Pharmacol. 2009 Oct;64(5):877-83. doi: 10.1007/s00280-009-0936-6. Epub 2009 Feb 4.

PMID:
19190908
10.

[A multi-centric phase I/II study of intraperitoneal docetaxel combined with S-1 for patients with peritoneal dissemination of gastric cancer].

Fushida S, Fujimura T, Fukushima N, Nashimoto A, Kaji M, Hirono Y, Yamaguchi K, Tanemura H, Imano M, Tsujitani S, Kurita N, Watanabe Y, Kurita A, Goda F, Ohta T.

Gan To Kagaku Ryoho. 2007 Nov;34(12):1942-5. Japanese.

PMID:
18219859
11.

Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer.

Yoshida K, Ninomiya M, Takakura N, Hirabayashi N, Takiyama W, Sato Y, Todo S, Terashima M, Gotoh M, Sakamoto J, Nishiyama M.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3402-7.

12.

A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer.

Rino Y, Takanashi Y, Yukawa N, Saeki H, Wada H, Kanari M, Yamada R, Satoh T, Yamamoto N, Imada T.

Anticancer Res. 2006 Mar-Apr;26(2B):1455-62.

13.

A multicenter, phase I dose-escalating study of docetaxel, cisplatin and S-1 for advanced gastric cancer (KDOG0601).

Nakayama N, Koizumi W, Sasaki T, Higuchi K, Tanabe S, Nishimura K, Katada C, Nakatani K, Takagi S, Saigenji K.

Oncology. 2008;75(1-2):1-7. doi: 10.1159/000151613. Epub 2008 Aug 22.

PMID:
18719348
14.

Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer.

Yamaguchi K, Shimamura T, Hyodo I, Koizumi W, Doi T, Narahara H, Komatsu Y, Kato T, Saitoh S, Akiya T, Munakata M, Miyata Y, Maeda Y, Takiuchi H, Nakano S, Esaki T, Kinjo F, Sakata Y.

Br J Cancer. 2006 Jun 19;94(12):1803-8.

15.

Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer.

Yoshida K, Hirabayashi N, Takiyama W, Ninomiya M, Takakura N, Sakamoto J, Nishiyama M, Toge T.

Anticancer Res. 2004 May-Jun;24(3b):1843-51.

16.

Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.

Ishigami H, Kitayama J, Kaisaki S, Hidemura A, Kato M, Otani K, Kamei T, Soma D, Miyato H, Yamashita H, Nagawa H.

Ann Oncol. 2010 Jan;21(1):67-70. doi: 10.1093/annonc/mdp260. Epub 2009 Jul 15.

17.

Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer.

Inada S, Tomidokoro T, Fukunari H, Sato T, Hatano T, Nishimura A, Kawauchi Y, Nikkuni K, Shimizu T, Sato T, Yanagi M, Takahashi S, Yoshida H, Sugita M, Hayashi T.

Cancer Chemother Pharmacol. 2009 Jan;63(2):267-73. doi: 10.1007/s00280-008-0736-4. Epub 2008 Apr 1.

PMID:
18379784
18.

Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer.

Inokuchi M, Yamashita T, Yamada H, Kojima K, Ichikawa W, Nihei Z, Kawano T, Sugihara K.

Br J Cancer. 2006 Apr 24;94(8):1130-5.

19.

Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer.

Lee JL, Kang HJ, Kang YK, Ryu MH, Chang HM, Kim TW, Sohn HJ, Kim H, Lee JS.

Cancer Chemother Pharmacol. 2008 Apr;61(5):837-45. Epub 2007 Jun 20.

PMID:
17579864
20.

Phase I/II study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer.

Kawabata R, Fujiwara Y, Doki Y, Fujita J, Tsukahara Y, Yamasaki M, Miyata H, Takiguchi S, Monden M.

Oncology. 2007;72(3-4):219-25. doi: 10.1159/000112945. Epub 2008 Jan 7.

PMID:
18176087
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk